{"id":3955,"date":"2020-08-26T09:17:53","date_gmt":"2020-08-26T09:17:53","guid":{"rendered":"https:\/\/clinlabint.3wstaging.nl\/17-oh-progesterone-elisa-with-neonatal-procedure\/"},"modified":"2021-01-08T11:21:32","modified_gmt":"2021-01-08T11:21:32","slug":"17-oh-progesterone-elisa-with-neonatal-procedure","status":"publish","type":"post","link":"https:\/\/clinlabint.com\/17-oh-progesterone-elisa-with-neonatal-procedure\/","title":{"rendered":"17 OH progesterone ELISA with neonatal procedure"},"content":{"rendered":"
The new 17 OH Progesterone Elisa (# KAP1401) uses a new polyclonal antibody and provides a validated extraction procedure for newborns serum samples. Extraction of the newborns samples is highly recommended in order to avoid any potential cross reaction with the 17OH-pregnenolone sulfate present in high concentration in very young infants. The DIAsource assay has the unique advantage to provide in the CE-IVD instructions for use a validated extraction procedure in addition to the corresponding expected concentration for newborns, men and women samples. Moreover the assay offers flexibility as it can be used on serum and EDTA\/Heparin plasma samples and is easily adaptable for open-system ELISA analysers. Lastly, the 24-month shelf-life allows end-users to store the kits for a long term period with no impact on the stability, quality and performance characteristics of the assay.<\/p>\n
\nSupplier:<\/strong> DIAsource ImmunoAssays
\nWebsite:<\/strong> <\/a><\/p>\n